Cambridge Investment Research Advisors, Inc. Iovance Biotherapeutics, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 41,869 shares of IOVA stock, worth $313,598. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,869
Previous 36,334
15.23%
Holding current value
$313,598
Previous $291,000
35.05%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IOVA
# of Institutions
313Shares Held
237MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.3MShares$205 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$199 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$180 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$159 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$98.9 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.18B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...